James J Litalien - Net Worth and Insider Trading
James J Litalien Net Worth
The estimated net worth of James J Litalien is at least $827,754 dollars as of 2024-05-13. James J Litalien is the SrVP/Chief Reg&Quality Officer of AveXis Inc and owns about 3,800 shares of AveXis Inc (AVXS) stock worth over $827,754. James J Litalien is also the Sr. V-P, Reg Affairs & Comp. of Ligand Pharmaceuticals Inc and owns about 0 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $0. Details can be seen in James J Litalien's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James J Litalien has not made any transactions after 2018-04-02 and currently still holds the listed stock(s).
Transaction Summary of James J Litalien
James J Litalien Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James J Litalien owns 2 companies in total, including AveXis Inc (AVXS) , and Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of James J Litalien’s form 4 insider trades.
Insider Ownership Summary of James J Litalien
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVXS | AveXis Inc | 2018-05-15 | SrVP/Chief Reg&Quality Officer |
| LGND | Ligand Pharmaceuticals Inc | 2006-03-10 | Sr. V-P & Reg Affairs & Comp. |
James J Litalien Latest Holdings Summary
James J Litalien currently owns a total of 2 stocks. Among these stocks, James J Litalien owns 3,800 shares of AveXis Inc (AVXS) as of April 2, 2018, with a value of $827,754 and a weighting of 100%. James J Litalien also owns 0 shares of Ligand Pharmaceuticals Inc (LGND) as of June 2, 2004, with a value of $0 and a weighting of 0%.
Latest Holdings of James J Litalien
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVXS | AveXis Inc | 2018-04-02 | 3,800 | 217.83 | 827,754 |
| LGND | Ligand Pharmaceuticals Inc | 2004-06-02 | 0 | 87.28 | 0 |
Holding Weightings of James J Litalien
James J Litalien Form 4 Trading Tracker
According to the SEC Form 4 filings, James J Litalien has made a total of 0 transactions in AveXis Inc (AVXS) over the past 5 years. The most-recent trade in AveXis Inc is the sale of 5,000 shares on April 2, 2018, which brought James J Litalien around $597,200.
According to the SEC Form 4 filings, James J Litalien has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 102 shares on June 2, 2004, which brought James J Litalien around $12,733.
Insider Trading History of James J Litalien
- 1
James J Litalien Trading Performance
James J Litalien Ownership Network
James J Litalien Owned Company Details
What does AveXis Inc do?
Who are the key executives at AveXis Inc?
James J Litalien is the SrVP/Chief Reg&Quality Officer of AveXis Inc. Other key executives at AveXis Inc include director & President & CEO Sean P. Nolan , 10 percent owner Ag Novartis , and Chief Financial Officer Phillip B. Donenberg .
AveXis Inc (AVXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
AveXis Inc Insider Transactions
James J Litalien Mailing Address
Above is the net worth, insider trading, and ownership report for James J Litalien. You might contact James J Litalien via mailing address: C/o Somaxon Pharmaceuticals, Inc., 3721 Valley Centre Drive, Suite 500, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
